Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 1/20 | 1.00 |
| ▸ | F3 | P13726 | 1/20 | 1.00 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 1.00 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 1.00 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 1.00 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 1.00 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 1.00 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 1.00 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | APP | P05067 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.65 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.65 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.63 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niacinamide SCHEMBL2926 | 1.00 | — | — | |
| Niacinamide SCHEMBL19978192 | 1.00 | — | — | |
| Niacinamide SCHEMBL29624874 | 1.00 | — | — | |
| Niacinamide SCHEMBL1063189 | 0.98 | F7 (0.96) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL2271609 | 0.98 | F7 (0.96) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL25366418 | 0.98 | — | — | |
| Niacinamide SCHEMBL9064246 | 0.98 | F7 (0.96) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL11410594 | 0.98 | F7 (0.96) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL6478235 | 0.98 | F7 (0.96) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL13935083 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113430170-A | Primary human intestinal cancer cell and culture method and application thereof | 北京和合医学诊断技术股份有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-113278589-A | Primary human intestinal cancer cell and culture method and application thereof | 北京和合医学诊断技术股份有限公司 | 2021-08-20 | — | — | CN | claimed |
| US-20090151598-A1 | combination of passivating agents which evaporate or sublimate to temporarily prevent metal corrosion in packaging; a C6-10 aliphatic monocarboxylic acid;a C6-10 aliphatic dicarboxylic acid; a primary aromatic amide; an aliphatic ester of hydroxybenzoic acid; a benzimidazole | EXCOR KORROSIONSFORSCHUNG GMBH (DE) | 2009-06-18 | — | — | US | claimed |
| WO-2024126604-A1 | PROCESS FOR PREPARING A COSMETIC ARTICLE AND COSMETIC ARTICLE THAT IS ADAPTABLE TO THE SHAPE OF THE FACE, NECK AND/OR NECKLINE AND CHARGED WITH HYDROPHILIC ACTIVE AGENT | L'OREAL (FR) | 2024-06-20 | — | — | WO | disclosed |
| CN-112569162-B | Synergistic effect of radix Ophiopogonis extract, amino acid derivative and calcium lactate hydrate | 默克专利股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| CN-116836933-B | Liver and gall cancer organoid culture solution, culture reagent combination and culture method | 北京大橡科技有限公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-116814551-B | Pancreatic cancer organoid culture solution, culture reagent combination and culture method | 北京大橡科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-116836933-A | Liver and gall cancer organoid culture solution, culture reagent combination and culture method | 北京大橡科技有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116814551-A | Pancreatic cancer organoid culture solution, culture reagent combination and culture method | 北京大橡科技有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023126397-A1 | KIT FOR CUSTOMIZING A COSMETIC COMPOSITION | L'OREAL (FR) | 2023-07-06 | — | — | WO | disclosed |
| WO-2005060711-A2 | METHODS OF TREATING A DISORDER | ELIXIR PHARMACEUTICALS, INC. (US) | 2005-07-07 | — | — | WO | disclosed |
| CN-1198580-C | Skin care compositions containing polysilicone elastomers | PROCTER & GAMBLE (US) | 2005-04-27 | — | — | CN | disclosed |
| WO-2005026112-A2 | METHODS OF TREATING A DISORDER | ELIXIR PHARMACEUTICALS, INC. (US) | 2005-03-24 | — | — | WO | disclosed |
| CN-1441665-A | Skin care compositions containing polysilicone elastomers | PROCTER & GAMBLE (US) | 2003-09-10 | — | — | CN | disclosed |
| EP-1207840-A4 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING THE APPEARANCE OF CELLULITE | MURAD HOWARD (US) | 2002-10-30 | — | — | EP | disclosed |
| EP-1207840-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING THE APPEARANCE OF CELLULITE | Murad, Howard (US) | 2002-05-29 | — | — | EP | disclosed |
| US-6207190-B1 | SYNERGISTIC MIXTURE TO REDUCE OCULAR PRESSURE AND IMPROVE VASCULAR HEALTH COMPRISING FOLIC ACID, A MAGNESIUM SALT, ALPHA-TOCOPHEROL, ASCORBATE AND ALPHA-LIPOIC ACID | CHRONORX, LLC | 2001-03-27 | — | — | US | disclosed |
| WO-2001013865-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING THE APPEARANCE OF CELLULITE | MURAD HOWARD (US) | 2001-03-01 | — | — | WO | disclosed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | disclosed |